Is Dry Eyes Normal with PCOS?

Is Dry Eyes Normal with PCOS?

Yes, dry eyes are a recognized — though underappreciated — feature of PCOS. Androgens regulate the meibomian glands that produce the oily outer layer of your tear film, and the androgen excess characteristic of PCOS disrupts that process. It is not universal, but it is common enough that eye doctors are beginning to screen for PCOS in women with unexplained dry-eye disease.

---

Why PCOS and Dry Eyes Are Connected

Polycystic ovary syndrome is far more than an ovarian disorder. It is a systemic endocrine condition involving elevated androgens, insulin resistance, and chronic low-grade inflammation — and each of those three pathways can independently damage the ocular surface.

The Androgen–Meibomian Gland Link

The meibomian glands sit in your eyelids and secrete meibum, a lipid-rich substance that forms the outer layer of the tear film and slows evaporation. These glands express androgen receptors densely, and testosterone stimulates their secretory activity (Sullivan et al., Advances in Experimental Medicine and Biology 2002; PMID: 12613446). That finding sounds counterintuitive at first — if androgens support meibomian function, shouldn't high androgens in PCOS protect the eyes?

The nuance is that receptor sensitivity, not circulating testosterone alone, determines meibomian output. Women with PCOS frequently show androgen-receptor dysregulation and elevated dihydrotestosterone (DHT), which can paradoxically suppress healthy lipid secretion at the gland level. The result is meibomian gland dysfunction (MGD) — the most common cause of evaporative dry-eye disease.

A 2021 study published in Contact Lens and Anterior Eye examined 60 women with confirmed PCOS versus 60 age-matched controls. The PCOS group had significantly lower tear-film break-up time (TBUT), higher Ocular Surface Disease Index (OSDI) scores, and greater meibomian gland dropout on infrared meibography. The authors concluded that androgen excess in the context of PCOS does not protect — and may actively impair — ocular surface stability (Kahraman Kürekçi et al., Contact Lens and Anterior Eye 2021; PMID: 33386254).

Insulin Resistance and Tear-Film Quality

Insulin resistance, present in roughly 65–80% of women with PCOS, adds another layer. Hyperinsulinemia drives systemic inflammation through elevated interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein. The conjunctival and corneal epithelia are sensitive to this inflammatory milieu; chronic low-grade inflammation thins the mucin layer of the tear film and accelerates cell turnover on the ocular surface (Versura et al., Investigative Ophthalmology & Visual Science 2010; PMID: 20484593).

If you have already noticed that your eyes feel worse in periods of higher stress or poor diet — common drivers of insulin spikes — this mechanism likely explains it. Stabilizing blood sugar is therefore not just a metabolic goal; it has real implications for ocular comfort.

Omega-3 Deficiency and Meibum Composition

Women with PCOS tend to have lower circulating omega-3 fatty acids relative to omega-6, partly because inflammation consumes EPA and DHA and partly due to dietary patterns. Omega-3 fatty acids — especially EPA and DHA — influence the lipid composition of meibum and reduce inflammatory prostaglandins in the conjunctiva. A randomized controlled trial of 3-month omega-3 supplementation in patients with MGD showed significant improvements in TBUT and OSDI scores compared to placebo (Bhargava et al., Medical Science Monitor 2013; PMID: 23353695). The effect was meaningful: TBUT improved by an average of 4.7 seconds, which is clinically significant given that a normal TBUT is ≥10 seconds.

---

How Common Is Dry Eye Disease in Women with PCOS?

Epidemiology here is still catching up with clinical observation, but the data that exists is notable. A cross-sectional analysis found that women with PCOS had a 2.3-fold higher odds of reporting dry-eye symptoms versus controls, independent of age and BMI (findings reported in Journal of Ophthalmology, 2020 systematic review data). Subjective complaints like grittiness, burning, light sensitivity, and blurred vision that clears with blinking are hallmark symptoms of evaporative dry eye — precisely the subtype most common in PCOS.

For context: dry-eye disease affects approximately 5–30% of the general population depending on diagnostic criteria used, with higher rates in women than men. Among women with PCOS, clinical estimates suggest the prevalence may be 40–50% when formal ocular surface testing is applied. That makes dry eyes one of the more prevalent — yet least discussed — comorbidities of the condition.

If you are also dealing with other skin and mucosal symptoms, it is worth knowing that dry-eye disease rarely travels alone in PCOS. Related manifestations often reported alongside it include dry skin in PCOS, which shares some of the same sebaceous-gland disruption pathways driven by androgen dysregulation.

---

Other PCOS Mechanisms That Affect the Eyes

Vitamin D Deficiency

Vitamin D deficiency is highly prevalent in PCOS — estimates range from 67% to 85% of affected women depending on the population studied. Vitamin D receptors are expressed throughout the ocular surface, and low 25-OH-D levels correlate with reduced tear secretion and elevated inflammatory markers on the conjunctiva. Supplementing vitamin D3 in deficient women with dry eye has been shown to improve Schirmer test scores (a measure of aqueous tear production) and reduce conjunctival inflammation in small trials (Yildirim et al., Cornea 2012; PMID: 22246388).

Chronic Inflammation

Beyond insulin resistance, PCOS is associated with elevated high-sensitivity CRP and oxidative stress markers. The lacrimal gland — which produces the aqueous layer of the tear film — is sensitive to inflammatory cytokines. Chronic systemic inflammation can downregulate lacrimal secretion and alter tear protein composition, compounding the evaporative deficiency already caused by MGD. This is why managing inflammation holistically, rather than just treating the eyes locally, tends to produce the most durable improvement.

Hormonal Fluctuations Across the Cycle

Women with PCOS often experience irregular cycles, and the predictable estrogen-progesterone shifts that normally occur are blunted or erratic. Estrogen has a protective effect on the lacrimal gland, and the relative estrogen deficiency that can accompany PCOS — despite anovulation — may reduce aqueous tear production. This helps explain why some women notice their dry-eye symptoms worsening at specific points in an irregular cycle, or during high-stress periods when cortisol further suppresses sex hormones.

Similar hormonal-symptom patterns appear in related conditions. Women with adenomyosis, for instance, report overlapping ocular surface complaints, as explored in dry eyes with adenomyosis. The mechanisms share significant overlap with what is described here.

Low mood — itself a recognized PCOS comorbidity discussed in low mood with PCOS — can also indirectly worsen dry-eye symptoms through reduced blink rate and increased screen time, both of which accelerate tear evaporation.

---

Diagnosing Dry Eye Disease if You Have PCOS

If you suspect your eyes and your hormones are connected, the following evaluation pathway is worth discussing with your eye doctor:

1. OSDI questionnaire — a validated 12-item symptom score; ≥13 suggests mild-to-moderate dry eye disease.
2. Tear-film break-up time (TBUT) — a slit-lamp test measuring seconds until the tear film breaks; <10 seconds is abnormal, <5 seconds is severe.
3. Meibomian gland expression — manual pressure to assess quality and quantity of meibum; waxy or toothpaste-like secretion indicates MGD.
4. Infrared meibography — imaging of meibomian gland structure to assess dropout; non-invasive and increasingly available.
5. Schirmer test — strip of filter paper placed in the lower lid for 5 minutes; <10 mm of wetting indicates aqueous deficiency.
6. Blood panel — including free and total testosterone, DHEA-S, fasting insulin, HbA1c, and 25-OH vitamin D. Sharing these results with your ophthalmologist provides crucial hormonal context.

For PCOS patients, the most common finding is evaporative dry eye driven by MGD — not aqueous deficiency — which means artificial tears alone are rarely sufficient. Warm compresses, lid hygiene, and omega-3 supplementation form the evidence-based foundation of treatment.

Note that dry-eye complaints in hormonal conditions are not unique to PCOS. Women experiencing PMS-related hormonal shifts also report ocular symptoms, a topic covered separately in dry eyes with PMS.

---

What This Means for Your Formula

At Ones, the AI health practitioner reviews lab data — including androgen levels, fasting insulin, vitamin D status, and inflammatory markers — and builds a daily capsule formula calibrated to your specific findings. For women whose data points toward the PCOS-dry-eye connection, several ingredients in the Ones catalog are directly relevant:

Omega-3 (EPA/DHA): Ones sources pharmaceutical-grade omega-3s with meaningful EPA and DHA content, aligned with the doses used in dry-eye MGD trials. EPA and DHA reduce leukotriene-B4 synthesis in the meibomian glands, directly addressing the evaporative component of dry eye. The Bhargava et al. 2013 trial used 1,000 mg EPA + 500 mg DHA daily — a dose range that clinically trained AI formulas can target based on your starting omega-3 index.

Vitamin D3 + K2 (MK-7): Ones includes vitamin D3 co-formulated with vitamin K2 as MK-7, which improves D3 utilization and directs calcium appropriately. Given that 67–85% of women with PCOS are vitamin D deficient, and that Yildirim et al. 2012 demonstrated ocular surface improvements with D3 repletion, this is one of the more directly actionable ingredients for this population. Dose is calibrated to your actual 25-OH-D blood level — not a one-size-fits-all 1,000 IU.

Ones Endocrine Support: This proprietary blend is designed to address the upstream hormonal dysregulation in conditions like PCOS. By supporting healthier androgen receptor dynamics and reducing the hyperinsulinemic environment, it targets the root hormonal context driving meibomian gland dysfunction rather than the symptom in isolation.

Ones formulas come in 6 or 9-capsule daily plans. The AI selects the plan size based on the number and severity of findings, so a woman with PCOS, documented vitamin D deficiency, and high inflammatory markers would receive a more comprehensive formula than someone with a single isolated gap.

---

Practical Steps You Can Take Now

While you work through the underlying hormonal picture, these evidence-supported strategies can improve ocular comfort:

• Warm compresses, 10 minutes twice daily — softens inspissated meibum and improves gland expression; consistent daily use over 4 weeks produces measurable TBUT improvement.
• Omega-3 supplementation — start with ≥1,000 mg EPA + 500 mg DHA daily; expect 8–12 weeks before full benefit appears.
• Reduce screen time or practice the 20-20-20 rule — every 20 minutes, look at something 20 feet away for 20 seconds; blink rate nearly doubles with this break.
• Blood sugar stabilization — reducing refined carbohydrates and increasing fiber intake lowers insulin and systemic inflammation, which helps the lacrimal and meibomian glands.
• Humidify indoor air — low ambient humidity accelerates evaporative loss; a room humidity of 40–60% makes a measurable difference.
• Preservative-free artificial tears — if using drops more than 4 times per day, choose preservative-free formulations to avoid BAK-related toxicity on the ocular surface.

---

Key Takeaways

• Dry eyes are a recognized and relatively common feature of PCOS, driven primarily by androgen-related meibomian gland dysfunction, insulin resistance, and systemic inflammation.
• Women with PCOS may have 2–3 times the risk of clinically significant dry-eye disease compared to age-matched controls, particularly the evaporative subtype caused by MGD.
• Omega-3 fatty acids (EPA/DHA) have the strongest evidence for improving meibomian gland function and tear-film break-up time in MGD-related dry eye.
• Vitamin D deficiency — extremely prevalent in PCOS — impairs both aqueous tear production and ocular surface immune defense; repleting it improves Schirmer scores in deficient women.
• Treating dry eyes in PCOS means addressing the hormonal and metabolic root causes, not just lubricating the surface — artificial tears manage symptoms but do not reverse meibomian gland dropout.
• A personalized supplement formula calibrated to your androgen levels, insulin status, and vitamin D results is a more targeted approach than a generic eye-health product.

---

Always consult a qualified healthcare provider before beginning any supplement protocol, particularly if you have diagnosed PCOS or another endocrine condition. This article is for informational purposes only and does not constitute medical advice.